Table 3.
PV seroprevalence of IPV-immunized children compared to OPV-immunized children in a previous study [10]
| No. of samples (%) | |||||
|---|---|---|---|---|---|
| All positive | PV1-negative | PV2-negative | PV3-negative | All negative | |
| IPV-immunized children (6–10 years, n = 236) | 195 (82.6%) | 16 (2.6%) | 8 (1.0%) | 29 (7.5%) | 3 (1.3%) |
| OPV-immunized children [10] (6–11 years, n = 500) | 411 (82.2%) | 13 (6.8%) | 5 (3.4%) | 38 (12.3%) | 0 (0%) |
| P value* | >0.05 | <0.01 | <0.05 | <0.05 | <0.05 |
* P < 0.05 indicates significant differences of seroprevalence among the compared groups.
IPV, inactivated polio vaccine; OPV, oral poliovirus vaccine; PV, poliovirus.